Private Portfolio Partners’s iShares Biotechnology ETF IBB Stock Holding History

Private Portfolio Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,702	Closed	-$205K	–	196
2019 Q4	$205K	Sell	1,702 -600	-26%	-$66.9K	0.09%	196
2019 Q3	$229K	Sell	2,302 -495	-18%	-$51.8K	0.11%	173
2019 Q2	$305K	Sell	2,797 -415	-13%	-$44.1K	0.13%	164
2019 Q1	$359K	Buy	3,212 +10	+0.3%	+$1.1K	0.19%	127
2018 Q4	$309K	Buy	+3,202	New	+$340K	0.19%	125

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Private Portfolio Partners's IBB Position: Q1 2020 in Review

Private Portfolio Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 1,702 shares — an estimated $205K sold.

Private Portfolio Partners first reported a position in IBB in Q4 2018 and held it in 5 quarters. The position peaked at $359K in Q1 2019. 668 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

Private Portfolio Partners reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
Private Portfolio Partners sold 1,702 iShares Biotechnology ETF shares in Q1 2020, an estimated $205K.
Private Portfolio Partners first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 5 quarters.
Private Portfolio Partners's iShares Biotechnology ETF position peaked at $359K in Q1 2019.
668 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Private Portfolio Partners's 13F filing for Q1 2020, filed 14 May 2020.